Engineering on a Natural Multivalent Antibody Platform: Solving Clinical Challenges with Experimental IgM Therapeutics

ESMO Targeted Anticancer Therapies Virtual Congress 2021 – March 1-2, 2021
Session: Multispecific Biological Constructs – March 2, 2021

Daniel S. Chen, MD, PhD, Chief Medical Officer
IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

ESMO TAT 20210302 DSC

Posted in publications.